Moderna has cut R&D expenditure and their shares has dropped 17%, maybe throw a few billion USD M&A at IMU for a new path to profitability. The big boys might bite.
"(Bloomberg) — Moderna Inc. (MRNA) aims to reduce its research and development budget by about 20% over the next three years as the biotech tries to find a path to profitability following disappointing vaccine sales.
The company is discontinuing five programs in its pipeline and slowing some late-stage studies of treatments for latent and rare diseases to achieve the $1.1 billion cut from its annual R&D budget by 2027, according to a statement Thursday.
The plan may appease investors who want to see the company avoid further losses. In a recent note, Jefferies analyst Michael Yee said Moderna needed to cut as much as $1 billion in expenses “to regain any investor confidence or credibility on profitability.”
Shares dropped by 17% in trading in New York on Thursday. Through Wednesday’s close, Moderna’s shares have dropped about 20% this year."
Media Thread, page-15527
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.004(8.16%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.5¢ | 4.8¢ | $1.798M | 35.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 2193808 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 605064 | 3 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |